These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7920222)

  • 21. Coupling of early response gene expression to distinct regulatory pathways during alpha-interferon and phorbol ester-induced plasmacytoid differentiation of B chronic lymphocytic leukaemia cells.
    Murphy JJ; Norton JD
    FEBS Lett; 1990 Jul; 267(2):242-4. PubMed ID: 2116321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory effects of IL-4 on human B-cell response to IL-2.
    Galanaud P; Karray S; Llorente L
    Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells.
    Hubmann R; Hilgarth M; Schnabl S; Ponath E; Reiter M; Demirtas D; Sieghart W; Valent P; Zielinski C; Jäger U; Shehata M
    Br J Haematol; 2013 Mar; 160(5):618-29. PubMed ID: 23278106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of alemtuzumab on neoplastic B cells.
    Golay J; Manganini M; Rambaldi A; Introna M
    Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of myogenic differentiation in a human rhabdomyosarcoma cell line by phenylacetate.
    Cinatl J; Cinatl J; Herneiz P; Rabenau H; Hovak M; Benda R; Gümbel HO; Kornhuber B; Doerr HW
    Cancer Lett; 1994 Apr; 78(1-3):41-8. PubMed ID: 8180967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
    Thomas A; Pepper C; Hoy T; Bentley P
    Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice.
    Di Benedetto M; Kourbali Y; Starzec A; Vassy R; Jozefonvicz J; Perret G; Crepin M; Kraemer M
    Br J Cancer; 2001 Sep; 85(6):917-23. PubMed ID: 11556846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
    Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
    Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
    Int J Cancer; 2005 Feb; 113(5):730-7. PubMed ID: 15499630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.
    Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A
    J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
    Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
    Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prohibitin expression is increased in phorbol ester-treated chronic leukemic B-lymphocytes.
    Woodlock TJ; Bethlendy G; Segel GB
    Blood Cells Mol Dis; 2001; 27(1):27-34. PubMed ID: 11162143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.
    Ghamlouch H; Darwiche W; Hodroge A; Ouled-Haddou H; Dupont S; Singh AR; Guignant C; Trudel S; Royer B; Gubler B; Marolleau JP
    Oncotarget; 2015 Jul; 6(21):18484-503. PubMed ID: 26050196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid.
    Kharbanda S; Datta R; Rubin E; Nakamura T; Hass R; Kufe D
    Cell Growth Differ; 1992 Jul; 3(7):391-9. PubMed ID: 1419903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
    Bosanquet AG; McCann SR; Crotty GM; Mills MJ; Catovsky D
    Acta Haematol; 1995; 93(2-4):73-9. PubMed ID: 7543720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term growth potential of cryopreserved B chronic lymphocytic leukemia cells in suspension and in semisolid medium.
    Vilpo J; Vilpo L
    Leukemia; 2001 Jun; 15(6):992-4. PubMed ID: 11417491
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses.
    Brown JR; Walker SR; Heppler LN; Tyekucheva S; Nelson EA; Klitgaard J; Nicolais M; Kroll Y; Xiang M; Yeh JE; Chaudhury M; Giaccone ZT; Fernandes SM; Jacobsen ED; Fisher DC; Freedman AS; Davids MS; Supko JG; Wu C; Frank DA
    Am J Hematol; 2021 Apr; 96(4):E95-E98. PubMed ID: 33373063
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating malignant precursors in monoclonal gammopathies.
    Caligaris-Cappio F; Bergui L; Gaidano GL; Schena M; Putto P; Merico F; Riva M
    Eur J Haematol Suppl; 1989; 51():27-9. PubMed ID: 2627991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.